Bruker (Nasdaq: BRKR) reported earnings on July 31. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended June 30 (Q2), Bruker beat expectations on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue increased. Non-GAAP earnings per share grew significantly. GAAP earnings per share increased significantly.

Gross margins dropped, operating margins grew, net margins increased.

Revenue details
 Bruker logged revenue of $454.9 million. The 13 analysts polled by S&P Capital IQ wanted to see revenue of $426.4 million on the same basis. GAAP reported sales were 8.1% higher than the prior-year quarter's $420.7 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures are normalized by S&P Capital IQ and may vary to maintain comparability with normalized estimates.

EPS details
 EPS came in at $0.18. The 13 earnings estimates compiled by S&P Capital IQ predicted $0.14 per share. Non-GAAP EPS of $0.18 for Q2 were 50% higher than the prior-year quarter's $0.12 per share. GAAP EPS of $0.14 for Q2 were 133% higher than the prior-year quarter's $0.06 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures are normalized by S&P Capital IQ and may vary to maintain comparability with normalized estimates.

Margin details
 For the quarter, gross margin was 44.3%, 40 basis points worse than the prior-year quarter. Operating margin was 9.6%, 400 basis points better than the prior-year quarter. Net margin was 5.0%, 260 basis points better than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
 Next quarter's average estimate for revenue is $454.8 million. On the bottom line, the average EPS estimate is $0.24.

Next year's average estimate for revenue is $1.82 billion. The average EPS estimate is $0.81.

Investor sentiment
 The stock has a three-star rating (out of five) at Motley Fool CAPS, with 249 members out of 265 rating the stock outperform, and 16 members rating it underperform. Among 55 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 52 give Bruker a green thumbs-up, and three give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Bruker is outperform, with an average price target of $19.50.

Looking for alternatives to Bruker? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.